Evidence map›Paper›PMID 33658303›Full record

ArticleLupus science & medicine2021

RNA tape sampling in cutaneous lupus erythematosus discriminates affected from unaffected and healthy volunteer skin.

Joseph F Merola, Wenting Wang, Carrie G Wager, Stefan Hamann, Xueli Zhang, Alice Thai, Christopher Roberts, Christina Lam, Cristina Musselli, Galina Marsh and 4 more

Open access · goldAbstract read
In one paragraph

Article in Lupus science & medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. What's New in Cutaneous Lupus Erythematosus: Guidelines, Biologics, and Beyond.The Journal of clinical and aesthetic dermatology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Joseph F MerolaDepartment of Dermatology and Department of Medicine, Division of Rheumatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Wenting WangBiogen Inc, Cambridge, Massachusetts, USA.
Carrie G WagerBiogen Inc, Cambridge, Massachusetts, USA.
Stefan HamannBiogen Inc, Cambridge, Massachusetts, USA.
Xueli ZhangBiogen Inc, Cambridge, Massachusetts, USA.
Alice ThaiBiogen Inc, Cambridge, Massachusetts, USA.
Christopher RobertsBiogen Inc, Cambridge, Massachusetts, USA.
Christina LamDermatology, Boston University, Boston, Massachusetts, USA.
Cristina MusselliBiogen Inc, Cambridge, Massachusetts, USA.
Galina MarshBiogen Inc, Cambridge, Massachusetts, USA.
Dania RabahBiogen Inc, Cambridge, Massachusetts, USA.
Catherine BarbeyBiogen Switzerland AG, Baar, Switzerland.
Nathalie FranchimontBiogen Inc, Cambridge, Massachusetts, USA.
Taylor L ReynoldsBiogen Inc, Cambridge, Massachusetts, USA taylor.reynolds@biogen.com.ORCID 0000-0002-6941-0900
Biogen (United States) · USBiogen (Switzerland) · CHBoston University · USBrigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePunch biopsy, a standard diagnostic procedure for patients with cutaneous lupus erythematosus (CLE) carries an infection risk, is invasive, uncomfortable and potentially scarring, and impedes patient recruitment in clinical trials. Non-invasive tape sampling is an alternative that could enable serial evaluation of specific lesions. This cross-sectional pilot research study evaluated the use of a non-invasive adhesive tape device to collect messenger RNA (mRNA) from the skin surface of participants with CLE and healthy volunteers (HVs) and investigated its feasibility to detect biologically meaningful differences between samples collected from participants with CLE and samples from HVs.

methodsAffected and unaffected skin tape samples and simultaneous punch biopsies were collected from 10 participants with CLE. Unaffected skin tape and punch biopsies were collected from 10 HVs. Paired samples were tested using quantitative PCR for a candidate immune gene panel and semi-quantitative immunohistochemistry for hallmark CLE proteins.

resultsmRNA collected using the tape device was of sufficient quality for amplification of 94 candidate immune genes. Among these, we found an interferon (IFN)-dominant gene cluster that differentiated CLE-affected from HV (23-fold change; p<0.001) and CLE-unaffected skin (sevenfold change; p=0.002), respectively. We found a CLE-associated gene cluster that differentiated CLE-affected from HV (fourfold change; p=0.005) and CLE-unaffected skin (fourfold change; p=0.012), respectively. Spearman's correlation between per cent area myxovirus 1 protein immunoreactivity and IFN-dominant mRNA gene cluster expression was highly significant (dermis, rho=0.86, p<0.001). In total, skin tape-derived RNA expression comprising both IFN-dominant and CLE-associated gene clusters correlated with per cent area immunoreactivity of some hallmark CLE-associated proteins in punch biopsies from the same lesions.

conclusionsA non-invasive tape RNA collection technique is a potential tool for repeated skin biomarker measures throughout a clinical trial.

Indexed as

Lupus Erythematosus, CutaneousCross-Sectional StudiesFemaleHealthy VolunteersHumansMaleRNASkinRNAautoimmune diseasesinterferon type Ilupus erythematosuspharmacogeneticssystemic

Identifiers

PMID33658303
PMCPMC7931768
OpenAlexW3133766358

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.